Point72 Asset Management
HELP

Point72 Asset Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Point72 Asset Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Buy
106,457
+86,773
+441% +$434K ﹤0.01% 3018
2026
Q1 		$94.5K Sell
19,684
-4,412,875
-100% -$28.5M ﹤0.01% 3618
2025
Q4 		$36.3M Buy
4,432,559
+3,192,930
+258% +$20.6M 0.04% 558
2025
Q3 		$7.3M Sell
1,239,629
-366,688
-23% -$2.6M 0.01% 925
2025
Q2 		$13.5M Buy
1,606,317
+788,352
+96% +$5.73M 0.03% 630
2025
Q1 		$5.19M Sell
817,965
-82,034
-9% -$710K 0.01% 910
2024
Q4 		$7.94M Buy
+899,999
New +$9.14M 0.02% 777
2024
Q2 		– Sell
-359,581
Closed -$5.65M – 1961
2024
Q1 		$5.65M Sell
359,581
-431,501
-55% -$6.23M 0.01% 929
2023
Q4 		$12.3M Buy
791,082
+292,398
+59% +$5.44M 0.03% 619
2023
Q3 		$10.1M Buy
+498,684
New +$7.34M 0.03% 655

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Point72 Asset Management's HELP Position: Q2 2026 in Review

Point72 Asset Management increased its Helus Pharma Inc. Common Stock (HELP) stake by 441% in Q2 2026, buying an estimated $434K and bringing the position to 106,457 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #3018.

Point72 Asset Management first reported a position in HELP in Q3 2023 and has held it in 10 quarters since. The position peaked at $36.3M in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Point72 Asset Management held 106,457 shares of Helus Pharma Inc. Common Stock worth $704K as of Q2 2026.
  • Point72 Asset Management bought 86,773 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $434K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3018 holding.
  • Point72 Asset Management first reported a position in Helus Pharma Inc. Common Stock in Q3 2023 and has held it in 10 quarters since.
  • Point72 Asset Management's Helus Pharma Inc. Common Stock position peaked at $36.3M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.